Skip to main content
. 2021 Apr 9;11:584884. doi: 10.3389/fonc.2021.584884

Figure 1.

Figure 1

Identification of the relationship between TME scores and prognosis of AML. (A) Survival curve of high and low immune groups: the survival rate of patients with high immune scores was significantly reduced (P = 0.021). (B) Survival curves of high and low stromal groups: the survival rate of patients with high stromal score decreased, with no significant statistical difference (P = 0.69). (C) Survival analysis showed that the survival rate of patients with high ESTIMATE score was significantly reduced (P = 0.011). (D–F) The distribution of the three scores in different FAB classifications are significantly different (all P values < 0.0001); (G–H) The relationship between the survival status of AML patients and three scores: the immune scores of the dead cases (P = 0.0093) and the ESTIMATE scores (P = 0.029) were significantly higher than those of the surviving patients, and the patients with high stromal scores were more likely to be in the state of death, but there was no significant statistical difference (P = 0.2).